Wang L - Search Results

1

[Clinical characteristics and outcome of 216 indolent B cell lymphomas].

Wang Y, Zhang L, Qian Y, Xu P, Wang L, Li J, Zhao W, Shen Z, Shen Y. Wang Y, et al. Among authors: wang l. Zhonghua Xue Ye Xue Za Zhi. 2016 Jan;37(1):61-4. doi: 10.3760/cma.j.issn.0253-2727.2016.01.012. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 26876256 Free PMC article. Chinese. No abstract available.

2

Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy.

Zhao X, Zhang W, Wang L, Zhao WL. Zhao X, et al. Among authors: wang l. Biomark Res. 2013 Aug 14;1(1):24. doi: 10.1186/2050-7771-1-24. Biomark Res. 2013. PMID: 24252620 Free PMC article.

3

[Mechanism of inhibiting the cell growth in diffuse large B-cell lymphoma by valproic acid combined with temsirolimus].

Zheng Z, Zhao Y, Dong LH, Wang L, Cheng S, Zhao WL. Zheng Z, et al. Among authors: wang l. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Dec;21(6):1441-7. doi: 10.7534/j.issn.1009-2137.2013.06.014. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 24370026 Chinese.

4

[Clinical analysis of 81 cases of malignant lymphoma treated with autologous hematopoietic stem cell transplantation].

Wang L, Fan L, Miao K, Xu J, Zhang R, Hong M, Zhu H, Shen W, Zhang X, Chen L, Qiu H, Lu H, Liu P, Wu H, Xu W, Li J. Wang L, et al. Zhonghua Xue Ye Xue Za Zhi. 2014 Apr;35(4):328-31. doi: 10.3760/cma.j.issn.0253-2727.2014.04.017. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24759022 Chinese.

5

[Double hit lymphoma: a case report and literatures review].

Fan L, Wang L, Xu J, Xu W, Li J. Fan L, et al. Among authors: wang l. Zhonghua Xue Ye Xue Za Zhi. 2014 Apr;35(4):348-9. doi: 10.3760/cma.j.issn.0253-2727.2014.04.022. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24759027 Chinese. No abstract available.

6

[Comparative analysis of decitabine combined with DAG regimen and other regimens in treatment of refractory/relapsed acute myeloid leukemia].

Hao J, Wang L, Wang Y, Liu Z, Gu X, Liu J, Li L, Duan Y, Chen Y, Zhao W, Shen Z. Hao J, et al. Among authors: wang l, wang y. Zhonghua Xue Ye Xue Za Zhi. 2014 Jun;35(6):481-5. doi: 10.3760/cma.j.issn.0253-2727.2014.06.001. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24985167 Chinese.

7

Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients.

Xu P, Yu D, Wang L, Shen Y, Shen Z, Zhao W. Xu P, et al. Among authors: wang l. Ann Hematol. 2015 Feb;94(2):239-47. doi: 10.1007/s00277-014-2188-8. Epub 2014 Sep 6. Ann Hematol. 2015. PMID: 25193354

8

[Comparison of HyperCVAD regimen and CHOP regimen in treating patients with lymphoblastic lymphoma].

Hu Y, Zhao X, Wu LL, Cai CP, Zhao WL, Wang L. Hu Y, et al. Among authors: wang l. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Jul;45(4):680-4. Sichuan Da Xue Xue Bao Yi Xue Ban. 2014. PMID: 25286699 Chinese.

9

c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors.

Zheng Z, Cheng S, Wu W, Wang L, Zhao Y, Shen Y, Janin A, Zhao WL. Zheng Z, et al. Among authors: wang l. J Hematol Oncol. 2014 Dec 5;7:88. doi: 10.1186/s13045-014-0088-y. J Hematol Oncol. 2014. PMID: 25477070 Free PMC article.

10

[Clinical characteristics and prognostic analysis of 90 patients with primary gastro-intestinal marginal zone lymphoma].

Zhao X, Wang L, Zhang S, Wang S, Sun Y, Zhao W. Zhao X, et al. Among authors: wang l, wang s. Zhonghua Xue Ye Xue Za Zhi. 2015 Jan;36(1):24-8. doi: 10.3760/cma.j.issn.0253-2727.2015.01.006. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 25641141 Free PMC article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146,426 results

Search Page

Filters